Cardiac sympathetic imaging with mIBG in heart failure

Cardiac sympathetic imaging with mIBG in heart failure

Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Cardiovascular imaging 2010-01, Vol.3 (1), p.92-100
Hauptverfasser: Carrió, Ignasi, Cowie, Martin R, Yamazaki, Junichi, Udelson, James, Camici, Paolo G
Format: Artikel
Sprache:eng
Schlagworte:
3-Iodobenzylguanidine
Arrhythmias, Cardiac - diagnostic imaging
Arrhythmias, Cardiac - etiology
Arrhythmias, Cardiac - physiopathology
Death, Sudden, Cardiac - etiology
Female
Heart - diagnostic imaging
Heart - innervation
Heart Failure - complications
Heart Failure - diagnostic imaging
Heart Failure - mortality
Heart Failure - physiopathology
Heart Failure - therapy
Humans
Male
Middle Aged
Predictive Value of Tests
Radiopharmaceuticals
Risk Assessment
Sympathetic Nervous System - diagnostic imaging
Sympathetic Nervous System - physiopathology
Tomography, Emission-Computed - methods
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cardiac sympathetic imaging with meta-iodobenzylguanidine (mIBG) is a noninvasive tool to risk stratify patients with heart failure (HF). In patients with ischemic and nonischemic cardiomyopathy, cardiac mIBG activity is a very powerful predictor of survival. Cardiac sympathetic imaging can help in understanding how sympathetic overactivity exerts its deleterious actions, which may result in better therapy and outcome for patients with HF.
ISSN:1936-878X
1876-7591
DOI:10.1016/j.jcmg.2009.07.014